Component,Publication Grant Number,Publication Doi,Publication Journal,Pubmed Id,Publication Title,Pubmed Url,Publication Year,Publication Keywords,Publication Authors,Publication Abstract,Publication Assay,Publication Tumor Type,Publication Tissue,Publication Dataset Alias,Publication Accessibility,PublicationView_id,Id,entityId,Dataset View_id
PublicationView,CA253547,10.1038/s41467-023-38271-5,Nat Commun,37173324,Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response,https://pubmed.ncbi.nlm.nih.gov/37173324,2023,,"Meghana Pagadala, Timothy J Sears, Victoria H Wu, Eva PÃ©rez-Guijarro, Hyo Kim, Andrea Castro, James V Talwar, Cristian Gonzalez-Colin, Steven Cao, Benjamin J Schmiedel, Shervin Goudarzi, Divya Kirani, Jessica Au, Tongwu Zhang, Teresa Landi, Rany M Salem, Gerald P Morris, Olivier Harismendy, Sandip Pravin Patel, Ludmil B Alexandrov, Jill P Mesirov, Maurizio Zanetti, Chi-Ping Day, Chun Chieh Fan, Wesley K Thompson, Glenn Merlino, J Silvio Gutkind, Pandurangan Vijayanand, Hannah Carter","With the continued promise of immunotherapy for treating cancer, understanding how host genetics contributes to the tumor immune microenvironment (TIME) is essential to tailoring cancer screening and treatment strategies. Here, we study 1084 eQTLs affecting the TIME found through analysis of The Cancer Genome Atlas and literature curation. These TIME eQTLs are enriched in areas of active transcrip(Read more on Pubmed)","RNA Sequencing, RT-PCR, Flow Cytometry",Pan-cancer,Not Applicable,Not Applicable,Open Access,37173324,314ec5fa-22c1-4b42-8d18-cc7dc99ab3e9,syn52566231,37173324
